Prescription

MRD / Regn No.

: 20160002977

Date

: 17/06/2026

Patient Name

: Killivalavan Elancheran

Age & Gender

: 67 Yrs. / Male

Contact No.

: 9791105313

UHID

:

Ht / Wt / BMI

:

BP S / BP D

:

Allergies

: NKA

Referred By

:

Problem List	:	TYPE 2 DM (01/Jan/2010) \| DYSLIPIDEMIA (27/May/2021) \| HYPERTENSION (17/Feb/2018) \| BENIGN PROSTATIC HYPERPLASIA (01/Jan/2021) \| A2G2 DKD (10/May/2024) \|
Subjective	:	HAS PAIN ABOVE THE KNEE
Objective	:	NONE
Analysis	:	TYPE 2 DM STABLE,EARLY SARCOPENIA,A2G1 DKD,EARLY PARKINSONS DISEASE
Plan	:	INCREASE SEMAGLUTIDE,HOLD SU
Salient Investigations	:	FASTING PLASMA GLUCOSE (FPG): 96 mg/dL \| POST PRANDIAL GLUCOSE (2HPP): 137 mg/dL

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	ROSUVASTATIN 10 MG ROSUVAS 10 MG	PO	0-0-1	AT BEDTIME இரவு தூங்கும்முன்	TILL NEXT VISIT
	MAY CAUSE FATIGUE AND MUSCLE PAIN

2	TELMISARTAN 40 MG TAZLOC 40 MG Medicine For HYPERTENSION KIDNEY PROTECTION	PO	0-0-1	AT BEDTIME இரவு தூங்கும்முன்	TILL NEXT VISIT

3	TERAZOSIN 2 MG HYTRIN 2 MG Medicine For PROSTATE	PO	0-0-1	AT BEDTIME இரவு தூங்கும்முன்	TILL NEXT VISIT
	MAY CAUSE DIZZINESS ESPECIALLY WITH FIRST DOSE. GET OUT OF BED SLOWLY

4	PIOZ 15 MG PIOGLITAZONE 15 MG		1-0-0	BEFORE FOOD உணவுக்கு முன்	TILL NEXT VISIT
	MAY CAUSE SWELLING OF THE FEET

5	INJECTION SEMAGLUTIDE 0.5 MG SUNDAE 0.5 MG Medicine For DIABETES HEART KIDNEY PROTECTION	SQ	ONCE A WEEK	AS DIRECTED NO RELATION TO FOOD
	MAY CAUSE GI OR VISUAL DISTURBANCES

Refill : 0 / Substitution:

Education

:

Next Visit

: 17/Jul/2026

Tests Suggested For Next Visit

: FBS 2HPP HBA1C